BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 6548171)

  • 21. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
    Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
    Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant lymphoma of the spleen in Japan: a clinicopathological analysis of 115 cases.
    Shimizu-Kohno K; Kimura Y; Kiyasu J; Miyoshi H; Yoshida M; Ichikawa R; Niino D; Ohshima K
    Pathol Int; 2012 Sep; 62(9):577-82. PubMed ID: 22924843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant lymphomas involving the prostate. A study of 13 cases.
    Bostwick DG; Mann RB
    Cancer; 1985 Dec; 56(12):2932-8. PubMed ID: 3840406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ultrasound involvement of the spleen in non-Hodgkin's lymphomas].
    Görg C; Weide R; Schwerk WB
    Ultraschall Med; 1995 Jun; 16(3):104-8. PubMed ID: 7667616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
    Rueffer U; Sieber M; Stemberg M; Gossmann A; Josting A; Koch T; Grotenhermen F; Diehl V;
    Ann Hematol; 2003 Jul; 82(7):390-6. PubMed ID: 12764547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases.
    Abbondanzo SL; Wenig BM
    Cancer; 1995 Mar; 75(6):1281-91. PubMed ID: 7882278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant splenic lymphoma: sonographic patterns, diagnosis and follow-up.
    Gorg C; Weide R; Schwerk WB
    Clin Radiol; 1997 Jul; 52(7):535-40. PubMed ID: 9240707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathological classification of malignant lymphomas in slaughtered swine.
    Hayashi M; Tsuda H; Okumura M; Sakata T; Ito N; Suchi T
    J Comp Pathol; 1988 Jan; 98(1):11-21. PubMed ID: 3279075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary extranodal non-Hodgkin's malignant lymphoma of the oral region: analysis of 11 autopsy cases.
    Takahashi H; Tezuka F; Fujita S; Okabe H
    J Oral Pathol; 1987 May; 16(5):241-50. PubMed ID: 3116185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary malignant lymphoma of the spleen.
    Sumimura J; Miyata M; Nakao K; Kamiike W; Yamaguchi T; Matsuda H
    Surg Today; 1992; 22(4):371-5. PubMed ID: 1392349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine needle aspiration biopsy of the spleen in the evaluation of neoplastic disorders.
    Silverman JF; Geisinger KR; Raab SS; Stanley MW
    Acta Cytol; 1993; 37(2):158-62. PubMed ID: 8465634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of nodal reactive follicular hyperplasia in the elderly patient with enlarged lymph nodes.
    Osborne BM; Butler JJ
    Mod Pathol; 1991 Jan; 4(1):24-30. PubMed ID: 2020658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the bone marrow by non-Hodgkin's lymphomas: incidence, histology and pathologic correlations.
    Baroni CD; Manente L; Occhionero M; Marzullo A; Mandelli F; Biagini C
    Tumori; 1981; 67(3):191-6. PubMed ID: 7025400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localized reactive lymphoid hyperplasia of the spleen simulating malignant lymphoma. A report of seven cases.
    Burke JS; Osborne BM
    Am J Surg Pathol; 1983 Jun; 7(4):373-80. PubMed ID: 6869666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
    Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
    J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.